Table 1.
Liposarcoma classification
| Clinical | Image (CT/NRM) | Anatomopathological | Molecular characteristics | Global survival rate | Relapse rate / Metastasis rate | |
|---|---|---|---|---|---|---|
| Atypical lipoma | Painless, soft tumor. Slow growth. Most common locations: extremities and retroperitoneum. Most common subtype | Encapsulated lipomatous mass (hyperintense in T1 and in T2 in NMR) with thick septations | Proliferation of mature adipocytes, with size variation, focal nuclear atypia, and/or fusiform cells | Amplification of MDM-2 and CDK-4 | 76-93% | (R) - 13-46% (extremities) (R) - 91% (retroperitoneum) (M) - almost zero |
| Undifferentiated LPS | May result from an atypical lipoma (10%). More frequent in retroperitoneum and extremities | Loss of signal intensity in images in T1 and focal nodules (>1 cm is suggestive) | Abrupt transition between mature adipocytes and high degree non-lipogenic sarcoma areas | Amplification of MDM-2 and CDK-4 | 54-64% | (R) - 18-57% (M) - 13-47% |
| Myxoid/ round cell LPS | Tumors more common in lower limbs. Affects young adults more frequently | Hypointensity of the signal in T1, and hyperintensity in T2 are pathognomonic | Predominance of round cell myxoid stroma. There is vascular system of thin walls (plexiform pattern) | FUS-CHOP gene fusion. Mutations PI3K (20%) | 40-75% | (R) - 7-28% (M) - 10-58% |
| Pleomorphic LPS | Rapid growth tumor. More frequent in old people and on extremities | Nonspecific mass, with frequent necrosis and hemorrhage necrosis | Intense cell atypia, irregular lipoblast. Hyperchromatic nuclei | Complex structural rearrangements | 0-63% | (R) - 16-45% (M) - 32-44% |
Abbreviations: LPS=Liposarcoma; CT= Computed tomography; NMR= Nuclear magnetic resonance; RT=Radiotherapy